Silica-coated ethosome as a novel oral delivery system for enhanced oral bioavailability of curcumin

Yaoxue Xuebao

Volumn 47, Issue 11, 2012, Pages 1541-1547

  Li, Chong ^a   Deng, Li ^a   Zhang, Yan ^a   Su, Ting Ting ^a   Jiang, Yin ^a   Chen, Zhang Bao ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

Curcumin; Ethosomes; Oral administration; Silica

Indexed keywords

ALCOHOL; CURCUMIN; DRUG CARRIER; ETHOSOME; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; CHINESE MEDICINE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; FEASIBILITY STUDY; GEL; IN VITRO STUDY; IN VIVO STUDY; PHARMACODYNAMICS; PHYSICAL CHEMISTRY; PRECIPITATION; SOLID;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; COATED MATERIALS, BIOCOMPATIBLE; CURCUMIN; DRUG CARRIERS; ETHANOL; LIPOSOMES; MALE; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SILICON DIOXIDE; SOLUBILITY;

EID: 84872533659     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers [J]. Nat Rev Drug Discov, 2005, 4: 145-160.
2. Wu Y, Zhang FC, Wu C, et al. Pharmacokinetics of epirubicin hydrochloride long-circulating thermosensitive liposomes in rat plasma [J]. Acta Pharm Sin, 2010, 45: 365-370.
3. Wang L, Yang CQ, Wang J. Assemble of magnetic nanoparticles into the structure of cisplatin liposome [J]. Acta Pharm Sin, 2011, 46: 592-598.
4. Fricker G, Kromp T, Wendel A, et al. Phospholipids and lipid-based formulations in oral drug delivery [J]. Pharm Res, 2010, 27: 1469-1486.
5. Rogers JA, Anderson ICE. The potential of liposomes in oral drug delivery [J]. Crit Rev Ther Drug Carrier Syst, 1998, 15: 421-480.
6. Chen Y, Lu Y, Chen J, et al. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt [J]. Int J Pharm, 2009, 376: 153-160.
7. Parmentier J, Becker MM, Heintz U, et al. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids [J]. Int J Pharm, 2011, 405: 210-217.
8. Ariën A, Goigoux C, Baquey C, et al. Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract [J]. Life Sci, 1993, 53: 1279-1290.
9. Chiang CM, Weiner N. Gastrointestinal uptake of liposomes. I. In vitro and in situ studies [J]. Int J Pharm, 1987, 37: 75-85.
10. Minato S, Iwanaga K, Kakemi M, et al. Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity [J]. J Control Release, 2003, 89: 189-197.
11. Li H, Song JH, Park JS, et al. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor [J]. Int J Pharm, 2003, 258: 11-19.
12. Chen H, Torchilin V, Langer R. Lectin-bearing polymerized liposomes as potential oral vaccine carriers [J]. Pharm Res, 1996, 13: 1378-1383.
13. Mu X, Zhong Z. Preparation and properties of poly(vinyl alcohol)-stabilized liposomes [J]. Int J Pharm, 2006, 318: 55-61.
14. Takeuchi H, Yamamoto H, Toyoda T, et al. Physical stability of size controlled small unilameller liposomes coated with a modified polyvinyl alcohol [J]. Int J Pharm, 1998, 164: 103-111.
15. Begu S, Aubert-Pouessel A, Lerner DA, et al. Liposil, a promising composite material for drug storage and release [J]. J Control Release, 2007, 118: 1-6.
16. Qi JJ, Yue XL, Wang Y, et al. Encapsulation and release of doxorubicin form silica-coated liposome [J]. J Clin Rehab Tissue Eng Res, 2009, 13: 4185-4188.
17. Bégu S, Durand R, Lerner DA, et al. Preparation and characterization of siliceous material using liposomes as template [J]. Chem Commun, 2003, 7: 640-641.
18. Dwivedi N, Arunagirinathan MA, Sharma S, et al. Silica-coated liposomes for insulin delivery [J]. J Nanomaterials, 2010, doi:10.1155/2010/652048.
19. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes [J]. Biomaterials, 2000, 21: 1879-1885.
20. Touitoua E, Dayana N, Bergelsonb L. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties [J]. J Control Release, 2000, 65: 403-418.
21. Ghosh SS, Salloum FN, Abbate A, et al. Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats [J]. Am J Physiol Heart Circ Physiol, 2010, 299: H975-984.
22. Soto-Cantu E, Cueto R, Koch J, et al. Synthesis and rapid characterization of amine-functionalized silica [J]. Langmuir, 2012, 28: 5562-5569.
23. Ringman JM, Frautschy SA, Cole GM, et al. A potential role of the curry spice curcumin in Alzheimer's disease [J]. Curr Alzheimer Res, 2005, 2: 131-136.
24. Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes [J]. Mol Ther, 2010, 18: 1606-1614.
25. Niu MM, Lu Y, Hovgaard L, et al. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation [J]. Int J Nanomed, 2011, 6: 1155-1166.
26. Guan PP, Lu Y, Qi JP, et al. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt [J]. Int J Nanomed, 2011, 6: 965-974.
27. Sun J, Deng Y, Wang S, et al. Liposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: development, characterization, and in vivo evaluation [J]. Drug Deliv, 2010, 17: 164-170.
28. Lescic I, Vukelic B, Majeric-Elenkov M, et al. Substrate specificity and effects of water-miscible solvents on the activity and stability of extracellular lipase from Streptomyces rimosus [J]. Enzyme Microb Technol, 2001, 29: 548-553.
29. Christophe B, John B, Linggen K, et al. Silica particles: a novel drug-delivery system [J]. Adv Mater, 2004, 16: 1-8.
30. Timo L, Christophe J, Jens M, et al. Nanostructured silica materials as drug-delivery systems for doxorubicin: single molecule and cellular studies [J]. Nano Lett, 2009, 9: 2877-2883.
31. Zhang Y, Wang J, Bai X, et al. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs [J]. Mol Pharm, 2012, 9: 505-513.
32. Pan L, He Q, Liu J, et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles [J]. J Am Chem Soc, 2012, 134: 5722-5725.
33. Kobayashi Y, Inose H, Nakagawa T, et al. Control of shell thickness in silica-coating of Au nanoparticles and their X-ray imaging properties [J]. J Colloid Interface Sci, 2011, 358: 329-333.
34. Didier B, Mercier R, Alberola ND, et al. Preparation of polyimide/silica hybrid material by sol-gel process under basic catalysis: Comparison with acid conditions [J]. J Polym Sci Pol Phys, 2008, 46: 1891-1902.